Figure 1a (Image 1)
Irbesartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72162-1035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 72162-1035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1b (Image 2)
Image02a (Image 3)
Image02b (Image 4)
Irbesartan Chemical Structure (Image 5)
Hctz Chemical Structure (Image 6)
Figure03 (Image 7)
This information appears to be dosage information regarding the medication Irbesartan. The doses listed are 150mg, 300mg, 450mg, 600mg, 750mg, and 900mg per day. However, there is no additional context provided, such as the purpose of the medication or any side effects associated with it.*
Figure04 (Image 8)
This is a chart which shows different doses (in mg/day) of a drug called Irbesartan. The doses include 150, 300, 450, 600, 750, and 900 mg/day. There is no further information available.*
Label (Lbl721621035)
This is a description of a medication that contains Irbesartan and Hydrochlorothiazide. The tablets are film-coated and each tablet has 150mg of Irbesartan and 12.5mg of Hydrochlorothiazide. The medicine should be kept away from children and stored at a temperature between 20 to 25 degrees Celsius. The medication is packaged in a bottle of 90 tablets and is available by prescription only. The manufacturer of the medication is Pliva Hrvatska d.o.o and it was repackaged by Bryant Ranch Prepack, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
